Tech Company Financing Transactions

Great Lakes Pharmaceuticals Funding Round

Great Lakes Pharmaceuticals closed a $3.1 million Series B funding round on 7/27/2010. Backers included CLS, Early Stage Partners and North Coast Angel Fund.

Transaction Overview

Announced On
7/27/2010
Transaction Type
Venture Equity
Amount
$3,100,000
Round
Series B
Investors

CLS (Lead Investor) (Gino DiSciullo)

Early Stage Partners (Michael Bunker)

North Coast Angel Fund

Ohio TechAngels Fund

Proceeds Purpose
The Company intends to use the funds to complete a pivotal clinical study of B-Lock, an antimicrobial catheter lock solution.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2000 Auburn Dr. 200
Beachwood, OH 44122
USA
Email Address
Overview
Great Lakes Pharmaceuticals develops products for the prevention of infections linked with indwelling catheters.
Profile
Great Lakes Pharmaceuticals LinkedIn Company Profile
Social Media
Great Lakes Pharmaceuticals Company Twitter Account
Company News
Great Lakes Pharmaceuticals News
Facebook
Great Lakes Pharmaceuticals on Facebook
YouTube
Great Lakes Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Gino DiSciullo
  Gino DiSciullo LinkedIn Profile  Gino DiSciullo Twitter Account  Gino DiSciullo News  Gino DiSciullo on Facebook
Chief Executive Officer
Krzysztof Appelt
  Krzysztof Appelt LinkedIn Profile  Krzysztof Appelt Twitter Account  Krzysztof Appelt News  Krzysztof Appelt on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/27/2010: Workstreamer venture capital transaction
Next: 7/28/2010: Verient venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary